the full-length TB-4 possesses substantially more human safety data than the fragment
Information here is drawn from the published trial record, FDA regulatory documents, and animal studies
Across the six published trials, the most common adverse events were headache, mild gastrointestinal effects (diarrhea, flatulence, nausea), nasopharyngitis, fatigue, dizziness, and mild injection-site reactions
Fix: Commit to minimum 8 weeks, preferably 12 weeks
Local rashes most often come from three mechanisms: An immune response to the medication itself, sending histamine to the injection area Sensitivity to an inactive ingredient like a preservative or buffer in the formulation Mechanical trauma from the needle or a fast injection technique The immune explanation is straightforward: a neighborhood-level alarm that sends histamine and inflammatory signals, producing redness and itch
Here's what you need to know: AOD 9604 is real, it works, but it's not magic
